Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention1: Individualized Homoeopathic medicines in centesimal potencies with lifestyle modification: Intervention is planned as administering indicated
homoeopathic remedies in centesimal potenc
dosage
and repetition depending upon the individual requirement of the cases. All
medicines will be procured from a Good Manufacturing Practice (GMP)-
certified firm. Along with medicine interventio
dosage and
repetition depending upon the individual requirement of the cases. Along with placebo comparator arm will also receive lifestyle modifications. Duration of therapy 6 months.
Sponsors
The Calcutta Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Cases attending OPD with ultra-sonographic evidence of grade-1 fatty liver. 2. Literate patients; ability to read and write in Bengali, Hindi, and/or English. 3. Patients giving written informed consent
Exclusion criteria
Exclusion criteria: 1.Cases too sick for consultation. 2. Patient unwilling to take part or not giving consent to join the study. 3. Diagnosed cases of viral hepatitis, Wilson disease, hemochromatosis, celiac disease, liver cirrhosis, hepatocellular carcinoma or any other malignancies or any uncontrolled systemic diseases, unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 4. Cases with history of usage of some drugs (e.g., amiodarone, corticosteroids, methotrexate, tamoxifen, synthetic estrogens, valproic acid, intravenous tetracycline, and highly active antiretroviral drugs) 5. Self-reported immune compromised state. 6. Alcohol or any other substance abuse and/or dependence. 7. Pregnant and lactating women. 8. Patient simultaneously taking part in other clinical trial in the same institute.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UltrasonographyTimepoint: at baseline & after 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| EQ-5D-5L QuestionnaireTimepoint: at baseline, after 3 months & after 6 months;Lipid profileTimepoint: at baseline, after 3 months & after 6 months;Liver function testTimepoint: at baseline, after 3 months & after 6 months | — |
Countries
India
Contacts
Public ContactProf Dr Himangsu Hait
The Calcutta Homoeopathic Medical College and Hospital
Outcome results
None listed